CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023
Cash flows from operating activities:
Net income (loss)	$ (4,683)	$ 1,358
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization of property and equipment	432	411
Amortization of intangible assets	15,996	13,113
Amortization of debt issuance costs	380	383
(Recovery of) provision for credit losses	59	(168)	$ 684
Loss on retirement of assets	0	4
Equity-based compensation expense	9,073	8,543
Change in fair value of contingent considerations	2,878	1,261
Lease abandonment expense	29	0
Deferred income taxes	(4,829)	(1,524)
Changes in assets and liabilities:
Accounts receivable	3,635	647
Prepaid expenses and other assets	(578)	559
Accounts payable, accrued expenses, and other liabilities	(14,825)	(13,596)
Deferred revenues	(3,271)	(1,034)
Net cash provided by operating activities	4,296	9,957
Cash flows from investing activities:
Capital expenditures	(619)	(317)
Capitalized software development costs	(2,959)	(2,360)
Investment in intangible assets	0	(54)
Net cash used in investing activities	(3,578)	(2,731)
Cash flows from financing activities:
Payments on long-term debt and finance lease obligations	(755)	(780)
Payments for business acquisition related contingent consideration	(8,649)	0
Payment of taxes on shares withheld for employee taxes	(943)	(70)
Net cash used in financing activities	(10,347)	(850)
Effect of foreign exchange rate changes on cash and cash equivalents, and restricted cash	(546)	1,174
Net (decrease) increase in cash and cash equivalents, and restricted cash	(10,175)	7,550
Cash and cash equivalents, and restricted cash, at beginning of period	234,951	239,688	$ 239,688
Cash and cash equivalents, and restricted cash, at end of period	224,776	247,238
Supplemental disclosures of cash flow information
Cash paid for interest	5,395	5,196
Cash paid for taxes	3,640	517
Supplemental schedule of noncash investing and financing activities
Issuance of common stock for business acquisition related contingent consideration	$ 3,707	$ 0